Analysis Supports Role of Lotilaner Ophthalmic Solution for Demodex Blepharitis
In a systematic review and meta-analysis of available data, lotilaner ophthalmic solutions outperformed placebo, with few side effects, in treating Demodex blepharitis.
Stay updated with breaking news from Ophthalmic Solution. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In a systematic review and meta-analysis of available data, lotilaner ophthalmic solutions outperformed placebo, with few side effects, in treating Demodex blepharitis.
Several drugs are either banned or withdrawn after introduction in the market.
As the final market day of FY23-24 concluded, Indian markets experienced one of their best years, with the Nifty ranking among the top-performing markets in Asia, yielding nearly 29% USD return (second only to Japan). Conversely, China and Hong Kong faced significant underperformance.
The company's board will meet later in the day to consider and take on record the unaudited standalone and consolidated results of the company for the quarter and nine-months ended December 31, 2023
Lupin has received the FDA's nod for generic Inderal LA ER Capsules, and the company has introduced generic Chantix and generic Prolensa.